Search Within

Mary Ellen Moynahan

Formats
  1. Journal Article (56)
  2. Meeting Abstract (46)
  3. Conference Paper (2)
  4. Book Section (1)
Groups
  1. Breast Medicine Service (105)
  2. Department of Medicine (105)
  3. Solid Tumor Oncology Division (105)
  4. Survivorship Research (59)
  5. GSK Faculty (52)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)

More Groups

People
  1. Clifford Hudis (54)
  2. Larry Norton (38)
  3. Maria Jasin (30)
  4. Andrew Seidman (28)
  5. Teresa Gilewski (26)
  6. Gabriella D'Andrea-Carlino (25)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (2)
  4. 2017 (2)
  5. 2016 (9)
  6. 2015 (10)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Cancer Research (14)
  3. Breast Cancer Research and Treatment (12)
  4. Clinical Cancer Research (8)
  5. Proceedings of the National Academy of Sciences of the United States of America (4)
  6. Clinical Breast Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. American Association for Cancer Research (23)
  3. Springer (12)
  4. Elsevier Inc. (11)
  5. Nature Publishing Group (5)
  6. Cell Press (4)

More Publishers

Results (105)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRCA2: Safeguarding the genome through homologous recombination
    Book Section

    Christ, N.; Moynahan, M. E.; Jasin, M.
    In Aguilera, A.; Rothstein, R. (Eds.) Molecular Genetics of Recombination (2007)

    Fulltext@MSK | Save
  • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    Meeting Abstract

    Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • PIK3CA mutation is frequent in class A estrogen receptor-negative breast cancer and contributes to the distinct molecular profile
    Meeting Abstract

    Doane, A. S.; Moynahan, M. E.; Zhang, L.; Hudis, C.; Gerald, W. L.
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Distinct PIK3CA mutation profiles in estrogen receptor (ER) negative breast cancer (BC) subsets
    Meeting Abstract

    Doane, A. S.; Danso, M.; Lal, P.; Donaton, M.; Wheler, J.; Moynahan, M.; Zhang, L.; Hudis, C.; Gerald, W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Serum peptide profiling (SPP) by mass spectrometry (MS) to identify postmenopausal women with metastatic breast cancer
    Meeting Abstract

    Smith, K. L.; Villanueva, J.; D'Andrea, G.; Moynahan, M. E.; Sklarin, N.; Norton, L.; Hudis, C.; Tempst, P.; Robson, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Mammary cancers in mice expressing mutated Rad51
    Meeting Abstract

    Shulemovich, E.; Tornos, C.; Jasin, M.; Moynahan, M. E.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer
    Journal Article

    Modi, S.; Seidman, A. D.; Dickler, M.; Moasser, M.; D'Andrea, G.; Moynahan, M. E.; Menell, J.; Panageas, K. S.; Tan, L. K.; Norton, L.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save